Skip to main content

Advertisement

Table 1 Baseline clinical and laboratory characteristics of 107 hypertensive type 2 diabetic patients

From: Hypertension management algorithm for type 2 diabetic patients applied in primary care

Baseline  
N 107
Age (years) 62.6 ± 11.2
White ethnicity – n (%) 88 (82.2%)
Female sex– n (%) 69 (64.5%)
Diabetes duration (years) 8.3 ± 9.2
Primary care unit attendance (years) 2.3 ± 2.7
Previous cardiovascular event – n (%) 21 (19.2%)
Current Smoking – n (%) 9 (8.4%)
SBP (mmHg) 145.3 ± 21.6
DBP (mmHg) 79.0 ± 11.4
BMI (kg/m2) 30.2 ± 5.9
Using statin – n (%) 47 (44%)
Using aspirin– n (%) 66 (61.8%)
Microalbuminuria– n (%) 25 (23.4%)
Diabetes Treatment - n (%)  
 Diet only 11 (10.3%)
 One agent 46 (43%)
 Two agents 42 (39.2)
 Three agents 8 (7.5%)
   Insulin use 23 (21.5%)
Hypertension Treatment  
 No drugs 11 (10.3%)
 One agent 28 (26.2%)
 Two agents 46 (43%)
 Three agents 16 (15%)
 Four agents 6 (5.5%)
   Diuretic 69
   ACE inhibitor 76
   β-blocker 36
   Calcium channel blocking 15
Total cholesterol (mg/dl) 179.9 ± 39.7
HDL cholesterol (mg/dl) 48.0 ± 11.3
Triglycerides (mg/dl) 152 (107.3 -368.7)
LDL cholesterol (mg/dl) 100.6 ± 28.4
HbA1c (%) 7.3 ± 1.6
  1. Data are mean ± SD, number of patients with the characteristic (%).